Fortress Biotech, Inc. (FBIO) vs Fractyl Health, Inc. (GUTS)

Fortress Biotech, Inc. and Fractyl Health, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Fractyl Health, Inc. are of similar size ($76.4M and $76.0M). Fractyl Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −22.5%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 16 metrics below, Fortress Biotech, Inc. leads on 12 and Fractyl Health, Inc. on 4.

Valuation

Metric FBIO GUTS Biotechnology median
P/E 0.70 n/m 7.88
P/S 1.06 835.89 11.47
P/B 0.35 n/m 2.52
Price to free cash flow 0.84 n/m 21.16
EV/EBITDA 4.22 n/m 0.74
EV/Sales (1.25) 656.39 10.73
Earnings yield 142.98% (179.59%) (28.84%)
Free cash flow yield 118.43% (106.75%) (23.03%)

Profitability

Metric FBIO GUTS Biotechnology median
Gross margin 65.59% 46.24% 65.16%
Operating margin (42.61%) 0.00% 0.00%
Net margin 150.98% 0.00% 0.00%
Free cash flow margin 183.80% 0.00% 0.00%
Return on equity 84.91% 1,063.04% (57.72%)
Return on assets 43.38% (146.75%) (49.22%)
Return on invested capital (41.34%) 0.00% 0.00%

Growth

Metric FBIO GUTS Biotechnology median
Revenue growth (TTM) 15.46% (22.50%) 5.64%
EPS growth (last fiscal year) 97.40% (14.81%) —
Revenue growth, 5-year CAGR 6.77% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric FBIO GUTS Biotechnology median
Debt to equity 0.17 (18.29) 0.00
Current ratio 3.96 3.15 4.73
Net debt to EBITDA 0.43 0.53 0.96

Dividend

Metric FBIO GUTS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric FBIO GUTS Biotechnology median
Market cap 76.04m 76.41m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack